Literature DB >> 647442

Influence of phenobarbital and diphenylhydantoin on the healing of rickets in the rat.

M Gascon-Barré, M G Côté.   

Abstract

Male weanling Sprague-Dawley rats were administered phenobarbital or diphenylhydantoin (phenytoin, dilantin, DPH), or a combination of the two drugs, while receiving a high calcium, low phosphorus vitamin D-deficient diet. A Line Test evaluation for calcification of the distal end of the radius was performed to determine the presence of rickets and the healing of the disease. After a period of 16 days, rickets had developed in a uniform manner in all groups regardless of drug treatment. Four I.U. of vitamin D3 were then administered to each animal and they were sacrificed either 3 or 9 days later. Three days after the administration of D3, bone calcification had started in all groups, with the greatest response being observed in the control group. Nine days after D3 administration, bone calcification was clearly impaired in PB and PB-DPH treated animals and slightly impaired in the DPH treated group when compared to controls. Weight gain was also impaired after PB and combined PB-DPH treatments. Based on these observations, it is suggested that anticonvulsant drugs, and in particular PB, inhibit, in a yet undetermined fashion, the normal calcification of the growth cartilage which accompanies a single physiological dose of cholecalciferol in the rat.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647442     DOI: 10.1007/BF02010756

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


  29 in total

1.  Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs.

Authors:  A H CONNEY; C DAVISON; R GASTEL; J J BURNS
Journal:  J Pharmacol Exp Ther       Date:  1960-09       Impact factor: 4.030

2.  Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia.

Authors:  C Christiansen; P Rodbro; O Munck
Journal:  Br Med J       Date:  1975-05-17

3.  Diphenylhydantoin: direct inhibition of the vitamin D3-mediated calcium absorptive mechanism in organ-cultured duodenum.

Authors:  R A Corradino
Journal:  Biochem Pharmacol       Date:  1976-04-01       Impact factor: 5.858

4.  Retarded growth of rats by anticonvulsant drugs.

Authors:  D Kraft; D von Herrath; K Schaefer
Journal:  Epilepsia       Date:  1974-03       Impact factor: 5.864

5.  Effect of phenobarbitone treatment on vitamin D metabolism in mammals.

Authors:  J Silver; G Neale; G R Thompson
Journal:  Clin Sci Mol Med       Date:  1974-04

6.  Vitamin D-dependency rickets in institutionalized, mentally retarded children on long term anticonvulsant therapy. II. The response to 25-hydroxycholecalciferol and to vitamin D2.

Authors:  N Maclaren; F Lifshitz
Journal:  Pediatr Res       Date:  1973-11       Impact factor: 3.756

7.  Intestinal absorption of vitamin D 3 in epileptic patients and phenobarbital-treated rats.

Authors:  K Schaefer; D Kraft; D von Herrath; A Opitz
Journal:  Epilepsia       Date:  1972-08       Impact factor: 5.864

8.  Effect of diphenylhydantoin on hepatic drug hydroxylation.

Authors:  F Petruch; R V Schüppel; G Steinhilber
Journal:  Eur J Clin Pharmacol       Date:  1974-07-26       Impact factor: 2.953

9.  Disturbance of calcium metabolism by anticonvulsant drugs.

Authors:  A Richens; D J Rowe
Journal:  Br Med J       Date:  1970-10-10

Review 10.  Diphenylhydantoin metabolism. A prospective review.

Authors:  A J Glazko
Journal:  Drug Metab Dispos       Date:  1973 Sep-Oct       Impact factor: 3.922

View more
  1 in total

1.  Sequential changes in mineral metabolism and serum vitamin D metabolite concentrations produced by phenobarbital administration in the rat.

Authors:  T J Hahn; L R Halstead
Journal:  Calcif Tissue Int       Date:  1983-05       Impact factor: 4.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.